ScreenACT
Revolutionising Patient Recruitment for Clinical Trials

In the realm of oncology research, a multitude of clinical trials offer hope for those seeking cutting-edge medical treatments for cancer patients. However, finding a clinical trial that aligns with a patient’s unique characteristics has traditionally been a complex and daunting task, leading to delays and missed opportunities.

Addressing this crucial need, ScreenACT, a revolutionary tech startup, is transforming the way cancer patients connect with suitable oncology clinical trials. It is poised to redefine how patients discover life-changing medical treatments and find the right doctors by offering an innovative model of decentralized clinical trials that can be opened wherever there is a need. This extends the reach of clinical trials by making them accessible to peripheral centers, while providing more equitable access for patients whose reach is limited to available clinical trials near them.

Its platform’s user-friendly interface caters to patients and healthcare professionals, with separate applications tailored to their distinct requirements. While it allows physicians to search and refer patients to the right clinical trial, patients can also access trial information and choose to participate in it.

“Our applications create a perfect relationship between patients and clinical trials while aiming to improve and expedite the patient recruitment process,” says Arthur Delort, co-founder and CTO of ScreenACT.

Traditionally, clinical trials are conducted in specific centres, forcing patients to travel considerable distances for treatment. ScreenACT envisions a decentralised model in which trials are hosted on its platform, enabling patients to access information about trials conveniently close to their location.

Taking patient comfort a notch above, ScreenACT ensures the trials reach the patients if the latter cannot find a trial centre near them. The platform facilitates the opening of a trial centre in the patient’s immediate vicinity if they notify the platform about the absence of a nearby centre, enabling patients to access immediate treatment.

Currently operating within France, the platform provides a comprehensive view of all available clinical trials in the country. When zooming in on a specific city in the app, users can see the number of centres or clinical trials available.

Patients can dive deeper, exploring trials with precise filters. Whether it’s cancer type, patient age, location, or various other criteria, ScreenACT’s app empowers patients to pinpoint trials that align with their needs.

The company’s aspirations extend beyond connecting patients with clinical trials. It is carving a path towards becoming a contract research organisation, with the aim of enhancing the efficiency of the research centres hosting these trials. Its primary goal is to expedite the patient recruitment process, as trials that remain open for extended periods can prove expensive for the stakeholders.

ScreenACT’s data structuring stands out as one of its most impactful innovations. Unlike traditional platforms that often present clinical trial data in unstructured, text-heavy formats, structured data streamlines the process for patients seeking specific criteria. It has developed algorithms to analyse and classify clinical trials to enable quick identification when the user filters clinical trials on its platform.

The primary beneficiaries of ScreenACT are patients who gain access to a streamlined, user-friendly platform that enhances their chances of finding the right clinical trial. The trial centres also reap the rewards, as they can update their trial information through the application, ensuring that potential patients have accurate and up-to-date details. This level of transparency helps attract more participants to the trials.

Trial sponsors are also drawn to ScreenACT because of its platform’s ability to accelerate patient recruitment. Shortening the trial duration means a significant cost reduction, making the healthcare tech an attractive proposition for sponsors.

Our applications create a perfect relationship between patients and clinical trials while aiming to improve and expedite the patient recruitment process

During its two years of existence, ScreenACT has dedicated itself to improving the lives of patients facing daunting medical challenges, resulting in tremendous growth. It also reinvests a portion of its earnings into bolstering the medical infrastructure of clinical trial centres as a gesture of support.

The future is promising for ScreenACT. It is exploring numerous ideas for upcoming features on its platform, such as extending the data scope to new countries and integrating with other platforms. All the while, it will constantly work on maintaining data accuracy and improving the application performance and interface to provide a pleasant, seamless and snappy experience to the user.

ScreenACT’s journey is a testament to the power of innovation and compassion in the healthcare sector. As it plans to expand beyond France into new countries like Spain and Belgium, its impact on patients, clinical trial centres, physicians, and sponsors continues to grow, revolutionising the world of clinical trials one step at a time.